Zura Bio

ZURANasdaq Cayman Islands Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$432.189 M

$4.51 +0.22%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$68.7M

Loss-making

Shares outstanding

95,829,137

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#71Kyverna TherapeuticsKYTX$464.4M
#72Editas MedicineEDIT$448.5M
#73Zura BioZURA$432.2M
#74Cabaletta BioCABA$423.9M
#75C4 TherapeuticsCCCC$407.2M

What if Zura Bio were worth as much as…

Open the what-if tool →

Gold $30.2T

$315,498.72

Per share 69,955× higher

Bitcoin $1.74T

$18,174.59

Per share 4,030× higher

Nvidia $5.52T

$57,558.35

Per share 12,762× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Zura Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.